# Statin and Atheroma Vulnerability Evaluation

Study · id `cardio:ct-nct00997880` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00997880](<https://clinicaltrials.gov/study/NCT00997880>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00997880

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.

## Technical summary

Registry record NCT00997880. Randomized; triple masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 312 participants (enrolled count; ClinicalTrials.gov record NCT00997880, source copy `cardio:ctgov-nct00997880-2014-12-25`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT00997880, source copy `cardio:ctgov-nct00997880-2014-12-25`, retrieved 2026-10-26)
- Primary completion: 2014-12 (actual) (ClinicalTrials.gov record NCT00997880, source copy `cardio:ctgov-nct00997880-2014-12-25`, retrieved 2026-10-26)
- Completion: 2014-12 (actual) (ClinicalTrials.gov record NCT00997880, source copy `cardio:ctgov-nct00997880-2014-12-25`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT00997880, source copy `cardio:ctgov-nct00997880-2014-12-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00997880-2014-12-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Statin and Atheroma Vulnerability Evaluation
- Acronym: STABLE
- Condition: Coronary Artery Disease
- Intervention (Drug): Rosuvastatin calcium 40mg
- Intervention (Drug): Rosuvastatin calcium10mg
- Lead sponsor: Seung-Jung Park
- Lead sponsor class: OTHER
- Collaborator: CardioVascular Research Foundation, Korea
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Seung-Jung Park (`cardio:org-seung-jung-park`)
- Registry lists this organization as a collaborator: CardioVascular Research Foundation, Korea (`cardio:org-cardiovascular-research-foundation-korea`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study (`cardio:pubmed-27081016`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy (`cardio:pubmed-28679524`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b4234cafaaa6861002182a346fe9e73630ae600fb652115d97cb9c5807d9f091
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
